Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer.
Cancers (Basel). 2021 Apr 17;13(8):1941. doi: 10.3390/cancers13081941.
Cancers (Basel). 2021.
PMID: 33920531
Free PMC article.
Review.